Legionella pneumophila S1P-lyase targets host sphingolipid metabolism and restrains autophagy
- Inst. Pasteur, Paris (France); CNRS UMR 3525, Paris (France)
- Inst. Necker Enfants-Malades, Paris (France); Univ. Paris Descartes-Sorbonne Paris Cité, Paris (France)
- Centre de Recherches en Cancérologie de Toulouse (France); Inst. of Environmental Assessment and Water Research (IDAEA-CSIC), Barcelona (Spain)
- Univ. of Toronto, ON (Canada); Hospital for Sick Children, Toronto, ON (Canada)
- Monash Univ., Melbourne, VIC (Australia)
- Univ. of Toronto, ON (Canada)
- Univ. of Zurich (Switzerland)
- Univ. of Melbourne (Australia)
- Univ. of Melbourne at the Peter Doherty Inst. for Infection and Immunity, Melbourne, VIC (Australia)
- Centre de Recherches en Cancérologie de Toulouse (France)
- Monash Univ., Clayton, VIC (Australia)
Autophagy is an essential component of innate immunity, enabling the detection and elimination of intracellular pathogens. Legionella pneumophila, an intracellular pathogen that can cause a severe pneumonia in humans, is able to modulate autophagy through the action of effector proteins that are translocated into the host cell by the pathogen’s Dot/Icm type IV secretion system. Many of these effectors share structural and sequence similarity with eukaryotic proteins. Indeed, phylogenetic analyses have indicated their acquisition by horizontal gene transfer from a eukaryotic host. Here we report that L. pneumophila translocates the effector protein sphingosine-1 phosphate lyase (LpSpl) to target the host sphingosine biosynthesis and to curtail autophagy. Our structural characterization of LpSpl and its comparison with human SPL reveals high structural conservation, thus supporting prior phylogenetic analysis. Here, we show that LpSpl possesses S1P lyase activity that was abrogated by mutation of the catalytic site residues. L. pneumophila triggers the reduction of several sphingolipids critical for macrophage function in an LpSpl-dependent and -independent manner. LpSpl activity alone was sufficient to prevent an increase in sphingosine levels in infected host cells and to inhibit autophagy during macrophage infection. LpSpl was required for efficient infection of A/J mice, highlighting an important virulence role for this effector. Thus, we have uncovered a previously unidentified mechanism used by intracellular pathogens to inhibit autophagy, namely the disruption of host sphingolipid biosynthesis.
- Research Organization:
- Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
- Sponsoring Organization:
- USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH); Swiss National Science Foundation (SNSF)
- Grant/Contract Number:
- ANR-10-LABX-62-IBEID; ANR-13-IFEC-0003-02; GM074942; GM094585; AC02-06CH11357
- OSTI ID:
- 1239413
- Journal Information:
- Proceedings of the National Academy of Sciences of the United States of America, Vol. 113, Issue 7; ISSN 0027-8424
- Publisher:
- National Academy of SciencesCopyright Statement
- Country of Publication:
- United States
- Language:
- ENGLISH
Web of Science
Similar Records
Discovery of Ubiquitin Deamidases in the Pathogenic Arsenal of Legionella pneumophila
Legionella pneumophila inhibits immune signalling via MavC-mediated transglutaminase-induced ubiquitination of UBE2N